Brief: Climb Bio - Announces Initial Phase 1B Data For Budoprutug In Immune Thrombocytopenia
11/06/2026 12:03
BRIEF-Climb Bio - Announces Initial Phase 1B Data For Budoprutug In Immune Thrombocytopenia June 11 (Reuters) - Climb Bio Inc CLYM.O:
CLIMB BIO - ANNOUNCES INITIAL PHASE 1B DATA FOR BUDOPRUTUG IN IMMUNE THROMBOCYTOPENIA
CLIMB BIO - ENROLLMENT ONGOING IN 1000 MG COHORT WITH DATA EXPECTED BY YEAR-END 2026
Source text: ID:nGNX209x0t
Further company coverage: CLYM.O
((Reuters.Briefs@thomsonreuters.com;))